V-Set and Immunoglobulin domain containing 3, V-type immunoglobulin domain-containing suppressor of T-cell activation
The Human VSIG3 / VISTA Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between V-type immunoglobulin domain-containing suppressor of T-cell activation and its receptor V-Set and Immunoglobulin domain containing 3 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.
Form:
96-well Microplate
Samples:
Plasma, Serum, Antibodies, Proteins, Small Molecules, Peptides
Target:
VISTA (B7-H5 / PD-1H / VSIR), VSIG3
Application Notes:
Colorimetric
* VAT and and shipping costs not included. Errors and price changes excepted
